No Data
No Data
Titan Pharmaceuticals (TTNP.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $98,000; earnings per share of -$1.24, previous value of -$2.20.
Titan Pharmaceuticals (TTNP.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $98,000; earnings per share of -$1.24, previous value of -$2.20.
10-Q: Quarterly report
12 Health Care Stocks Moving In Monday's Intraday Session
GainersNRX Pharmaceuticals (NASDAQ:NRXP) shares increased by 39.5% to $2.93 during Monday's regular session. The company's market cap stands at $30.9 million. TC BioPharm (Holdings) (NASDAQ:TCBP) stoc
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersEmergent BioSolutions (NYSE:EBS) stock moved upwards by 98.4% to $3.83 during Thursday's regular session. The company's market cap stands at $200.6 million. The company's, Q1 earnings came out
Titan Pharmaceuticals Files FormRW Co Decided Not To Pursue The Offering Due To Market Conditions And No Longer Wishes To Conduct A Public Offering Of Securities At This Time, No Securities Covered By The Registration Statement Have Been Issued Or Sold.
Titan Pharmaceuticals Files FormRW Co Decided Not To Pursue The Offering Due To Market Conditions And No Longer Wishes To Conduct A Public Offering Of Securities At This Time, No Securities Covered By
12 Health Care Stocks Moving In Friday's After-Market Session
GainersMobile-health Network (NASDAQ:MNDR) shares rose 15.0% to $31.35 during Friday's after-market session. The company's market cap stands at $1.0 billion. Galera Therapeutics (NASDAQ:GRTX) stock in